Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-Cycloserine for Chronic Low Back Pain
NCT00125528Phase 2Completed
- Start
- Jul 2012
- Primary completion
- Apr 2014
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic low back pain (CLBP) comparing D-cycloserine with Placebo (2 arms). Primary endpoint: Numeric Rating Scale at 6 weeks. Started Jul 2012; status: completed.
02
Drugs
d-cycloserine
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT00125528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00125528.